- Half Year 2023 Mithra Pharmaceuticals SA Earnings Call TranscriptSep 26, 2023€1.77 (-15.00%)Earnings
- Q4 2022 Mithra Pharmaceuticals SA Earnings Call TranscriptMar 07, 2023€3.09 (+13.39%)Earnings
- Mithra Pharmaceuticals SA and Richter Gedeon Vegyeszeti Gyar Nyrt to Discuss Partnership for the Commercialisation of Donesta Presentation TranscriptDec 20, 2022
- Q2 2022 Mithra Pharmaceuticals SA Earnings Call TranscriptSep 23, 2022€6.6 (+2.96%)Earnings
- Full Year 2021 Mithra Pharmaceuticals SA Earnings Call TranscriptMar 08, 2022€13.7 (-12.85%)Earnings
- Mithra Pharmaceuticals SA to Discuss Donesta Top-Line Results Call TranscriptJan 14, 2022
- Half Year 2021 Mithra Pharmaceuticals SA Earnings Call TranscriptSep 24, 2021€17.8 (-3.78%)Earnings
- Full Year 2020 Mithra Pharmaceuticals SA Earnings Call TranscriptMar 09, 2021€23.4 (+9.35%)Earnings
- Half Year 2020 Mithra Pharmaceuticals SA Earnings Call TranscriptSep 24, 2020€16.86 (-1.29%)Earnings
- Mithra Pharmaceuticals SA at Jefferies Healthcare Conference (Virtual) TranscriptJun 03, 2020
Half Year 2020 Mithra Pharmaceuticals SA Earnings Call Transcript
Hello, and welcome to the Mithra Half Year Results 2020. My name is Josh, and I'll be your coordinator for today's event. Please note that this conference is being recorded. (Operator Instructions)
I will now hand you over to your host, Alexandra Deschner, to begin today's conference. Thank you.
Thank you very much, Josh, and welcome to Mithra's half year results webcast for analysts and investors. My name is Alexandra Deschner, Investor Relations Officer. This recorded webcast is accessible on the Mithra's homepage and will be available later today for replay.
I'd like to remind you that this webcast is covered by the safe harbor statement on Page 2 of the presentation. Forward-looking statements may be presented during our call that include statements about our future expectations, development pipeline, time lines, potential success of our product candidates, financial forecast and upcoming milestones. Actual results may vary, and Mithra is under no obligation to update these
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)